Loading...
Star Equity Holdings, Inc.
STRR•NASDAQ
Healthcare
Medical - Diagnostics & Research
$2.10
$-0.05(-2.33%)
Star Equity Holdings, Inc. (STRR) Financial Performance & Income Statement Overview
Review Star Equity Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
16.54%
↑ 16.54%
Operating Income Growth
-93.63%
↓ 93.63%
Net Income Growth
-141.53%
↓ 141.53%
Operating Cash Flow Growth
-292.03%
↓ 292.03%
Operating Margin
-13.49%
↓ 13.49%
Gross Margin
22.07%
↑ 22.07%
Net Profit Margin
-24.09%
↓ 24.09%
ROE
-23.85%
↓ 23.85%
ROIC
-10.10%
↓ 10.10%
Star Equity Holdings, Inc. (STRR) Income Statement & Financial Overview
Review Star Equity Holdings, Inc.'s (STRR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $17.09M | $13.66M | $13.48M | $9.12M |
| Cost of Revenue | $12.65M | $10.85M | $11.27M | $7.99M |
| Gross Profit | $4.45M | $2.82M | $2.22M | $1.13M |
| Gross Profit Ratio | $0.26 | $0.21 | $0.16 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $143000.00 | $7.42M | $5.34M | $4.09M |
| Operating Expenses | $866000.00 | $8.14M | $5.34M | $4.09M |
| Total Costs & Expenses | $13.51M | $18.98M | $16.61M | $12.08M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $374000.00 |
| Depreciation & Amortization | $1.08M | $1.03M | $795000.00 | $688000.00 |
| EBITDA | $4.67M | -$4.29M | -$2.92M | -$2.27M |
| EBITDA Ratio | $0.27 | -$0.31 | -$0.22 | -$0.25 |
| Operating Income | $3.58M | -$5.32M | -$3.12M | -$2.97M |
| Operating Income Ratio | $0.21 | -$0.39 | -$0.23 | -$0.33 |
| Other Income/Expenses (Net) | -$5.75M | $3.33M | -$703000.00 | $773000.00 |
| Income Before Tax | -$2.17M | -$1.99M | -$3.83M | -$2.19M |
| Income Before Tax Ratio | -$0.13 | -$0.15 | -$0.28 | -$0.24 |
| Income Tax Expense | $285000.00 | -$18000.00 | -$39000.00 | $35000.00 |
| Net Income | -$2.46M | -$1.97M | -$3.79M | -$2.22M |
| Net Income Ratio | -$0.14 | -$0.14 | -$0.28 | -$0.24 |
| EPS | -$0.95 | -$0.78 | -$1.34 | -$0.14 |
| Diluted EPS | -$0.95 | -$0.78 | -$1.34 | -$0.14 |
| Weighted Avg Shares Outstanding | $3.20M | $3.21M | $3.17M | $15.84M |
| Weighted Avg Shares Outstanding (Diluted) | $3.20M | $3.21M | $3.17M | $15.84M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan